NCT01692912View on ClinicalTrials.gov

Psoriatic Arthritis Treat to Target vs. Usual Care

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Psoriatic Arthritis (PsA)
Interventions
OTHER

Intensive Care

Rheumatologist aims to treat participant in order to achieve a disease activity score improvement of DAS28\<2.6

Trial Locations (4)

N6G 2S3

Pope Research Corp., 68 Green Acres Drive, London

Unknown

The Arthritis Program Research Group, Newmarket

M9C 5N2

Arthur Karasik, Toronto

H2L 1S6

Institut de Rheumatologie de Montreal, Montreal

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Pope Research Corporation

INDUSTRY